
MJ stock quote is a popular choice among investors, and for good reason. It's been a top performer in the cannabis industry.
MJ's market capitalization is around $2 billion, giving it a solid presence in the market. Its stock price has fluctuated over the years, but it's still a viable option for those looking to invest.
Investors can buy MJ stock through various online platforms, including Robinhood and Fidelity. This makes it easily accessible to a wide range of investors.
MJ's financials are publicly available, providing a clear picture of its revenue and expenses.
Additional reading: S B I Card Share Price
Medical Marijuana Inc.
Medical Marijuana Inc. is the first publicly held company vested in the cannabis and industrial hemp space in America. They manufacture and distribute CBD products worldwide through e-commerce, direct sales, retail, and wholesale distribution channels.
Medical Marijuana Inc. was instrumental in establishing the world's first supply chain of industrial hemp-derived cannabidiol (CBD) consumer products in 2012. This marked a significant milestone in the cannabis industry.
See what others are reading: Snapchat Stock Ticker Symbol
They have since expanded their operations, shipping to over 40 countries worldwide and making branded products available through various distribution channels. Medical Marijuana Inc. maintains its leadership through international expansion efforts.
In the U.S., Medical Marijuana Inc. developed and marketed the first fully THC-free version of CBD products. This innovation has contributed to the growth of the CBD market.
Their CEO, Raul Elizalde, addressed the World Health Organization at its hearings on CBD in November 2017, resulting in favorable outcomes for the CBD movement.
Intriguing read: Ventas Inc Stock
Industry News and Updates
The DEA is considering reclassifying cannabis from Schedule I to Schedule III, which could lead to a surge in cannabis stocks.
This move could bring tax breaks, access to banking services, and more efficient operations to the cannabis industry.
Pharmagreen Biotech, Inc. (PHBI) is a company that has been reported to be a potential beneficiary of this reclassification, with investors taking a close look at its prospects.
Cannabis stocks rallied sharply on Tuesday after a report by the Associated Press indicated that the DEA is poised to propose the lowering of cannabis to a Schedule III controlled substance.
Investors are optimistic about the future of cannabis stocks, with many believing that reclassification could bring significant benefits to the industry.
Possible cannabis reclassification is fueling optimism among fund managers, who see it as a major catalyst for growth in the sector.
Marijuana-related ETFs are trading higher in September after the HHS recommended that the U.S. reclassify and ease restrictions on marijuana.
Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cannabis companies.
You might like: What News Paper Should I Read for Trading Stocks Finance
Why Invest?
Investing in the cannabis industry can be a smart move, especially with the potential for growth and expansion. The global cannabis market is expected to show an annual growth rate of 14.06% from 2024 to 2028.
The MORE Act, sponsored by Kamala Harris, could give cannabis stocks a boost, as it aims to provide relief to those affected by the war on drugs. This could lead to increased investment and growth in the industry.
The global cannabis market is expected to reach a market volume of USD $102.9 billion by 2028, making it a potentially lucrative investment opportunity. There are many significant applications for cannabis and THC-based medicines and treatments, ranging from epilepsy to cancer treatment to non-opioid pain management.
Here are some key reasons to invest in the cannabis industry:
- Access the global cannabis industry through a U.S. ETF that targets this market.
- Be part of the transformation of medical treatments and explore the various applications of cannabis.
- Discover the worldwide growth potential of the global cannabis market.
Investing in the cannabis industry requires patience, but it's essential to stay optimistic in the long term. The industry is still evolving, and there are many opportunities for growth and expansion.
Performance and Holdings
The fund's inception date was December 2, 2015, and the index inception date was December 18, 2017. The performance data quoted represents past performance and does not guarantee future results.
Intriguing read: Ril Bonus Share Record Date
The fund's performance is tracked by the Prime Alternative Harvest Index, which focuses on companies within the cannabis ecosystem benefiting from global medicinal and recreational cannabis legalization initiatives. The index is unmanaged and it's not possible to invest directly in an index.
Here are the top 10 holdings in the fund, sorted by weight:
Performance
The performance of an investment is a crucial aspect to consider, and I'd be happy to break it down for you. The fund's inception date is December 2, 2015, and the index inception date is December 18, 2017.
The performance data quoted represents past performance, but it's essential to remember that past performance does not guarantee future results. The fund's investment return and principal value will fluctuate, so your shares may be worth more or less than the original cost when sold or redeemed.
The performance data is presented in a table, but unfortunately, the specific numbers are not available for the NAV, Closing Price, and Prime Alternative Harvest Index. However, we do know that the data is available for the Month end and Quarter end as of TBD.
If you're interested in tracking the fund's performance over time, you can look at the Annualized (%) and CUMULATIVE (%) returns, which are not yet available. But, we do know that the fund has been tracking the Prime Alternative Harvest Index since its inception on December 18, 2017.
Here's a summary of the available performance data:
Please keep in mind that the performance data is subject to change and may not reflect the current market conditions.
Top 10 Holdings
The Top 10 Holdings of the fund are quite revealing. The Amplify Seymour Cannabis ETF takes the lead with a whopping 40.05% weight.
The top 5 holdings are dominated by cannabis companies, with Tilray Brands, Inc. coming in second at 8.05%. SNDL Inc. follows closely with a 7.62% weight.
Here are the top 10 holdings of the fund:
MJ Distributions
MJ Distributions are a key aspect of the Fund's performance. The distributions are made quarterly, with the first distribution of the year typically occurring in March.
The amount of each distribution varies, with a range of $0.0200 to $2.2122 per share. For example, the first distribution of 2020 was $0.1000 per share.
Some distributions are more significant than others, such as the final distribution of 2016, which was $2.2122 per share. This is a notable increase compared to the smaller distributions made throughout the year.
Looking at the data, we can see that the Fund has made distributions every quarter since 2016. This consistency is a testament to the Fund's stable performance.
Here's a breakdown of the distribution amounts for each year:
These figures give us a sense of the Fund's distribution history and the variability in the amount of each distribution.
Featured Images: pexels.com


